DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Ind-Swift Laboratories Limited — Change in Directors/KMP/SMP/Auditor/RTA

NSE 2 hrs ago·2 Sept 2026, 1:30 pm

IND Swift Laboratories LT

Ind-Swift Laboratories Limited has informed stock exchanges about a change in its key personnel. The company has appointed a new Director and Key Managerial Personnel (KMP), replacing the previous incumbents. Additionally, the firm has updated its Statutory Auditors and Registrars and Transfer Agents (RTA).

This administrative update does not directly impact the company's core operations or business strategy. However, it is important for investors to monitor the new leadership's background and expertise to ensure continuity in management. Changes in auditors and RTAs can sometimes lead to procedural adjustments, so investors should stay informed about any related announcements.